Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N.
Liu Y, et al.
FASEB J. 2019 May;33(5):6239-6253. doi: 10.1096/fj.201801783RR. Epub 2019 Feb 21.
FASEB J. 2019.
PMID: 30789757
Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.-Liu, Y., Harashima, S., Wang, Y., Suzuki, K., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, …
Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.-Liu, …